CervoMed Inc. Gain (Loss) on Derivative Instruments, Net, Pretax
CervoMed Inc. (CRVO) reported Gain (Loss) on Derivative Instruments, Net, Pretax of -$8.98 million for the 6-month period ending 2013-06-30, per its 10-Q filed 2013-08-14.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDerivativeInstrumentsNetPretax · last filed 2013-08-14
- CervoMed Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2013-06-30 was -$8.74M, a 163.26% decline year-over-year.
- CervoMed Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2013-03-31 was -$236.85K, a 111.57% decline year-over-year.
- CervoMed Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2012-06-30 was $13.82M.
- CervoMed Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2012-03-31 was $2.05M.
| Period end | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month |
|---|---|---|
| 2013-06-30 | -$8.74M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-08-14 | -$8.98M 10-Q · filed 2013-08-14 |
| 2013-03-31 | -$236.85K 10-Q/A · filed 2013-05-20 | |
| 2012-06-30 | $13.82M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-08-14 | $15.87M 10-Q · filed 2013-08-14 |
| 2012-03-31 | $2.05M 10-Q/A · filed 2013-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |